Bruker (BRKR)
(Delayed Data from NSDQ)
$65.88 USD
-2.45 (-3.59%)
Updated Aug 2, 2024 04:00 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Bruker (BRKR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$82.80 | $102.00 | $60.00 | 25.68% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for Bruker comes to $82.80. The forecasts range from a low of $60.00 to a high of $102.00. The average price target represents an increase of 25.68% from the last closing price of $65.88.
Analyst Price Targets (10)
Broker Rating
Bruker currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 1.80 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, seven are Strong Buy, representing 70% of all recommendations. A month ago, Strong Buy represented 70%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 6 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.80 | 1.80 | 1.80 | 1.89 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/3/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
5/20/2024 | Not Identified | Not Identified | Hold | Hold |
4/12/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
4/10/2024 | Goldman Sachs | Matthew Sykes | Strong Sell | Strong Sell |
4/1/2024 | Cowen & Co. | Daniel Brennan | Hold | Hold |
3/1/2024 | UBS | John N Sourbeer | Strong Buy | Strong Buy |
12/13/2023 | Not Identified | Not Identified | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 10 |
Average Target Price | $82.80 |
LT Growth Rate | 10.80% |
Industry | Instruments - Scientific |
Industry Rank by ABR | 103 of 253 |
Current Quarter EPS Est: | 0.52 |